Gilead, Teva Ink 11th-Hour HIV Antitrust Deal With Pharmacies
With openings set to begin Thursday in an antitrust trial over claims Gilead and Teva illegally inflated HIV drug prices, the two drugmakers struck a last-minute deal with major pharmacies, and...To view the full article, register now.
Already a subscriber? Click here to view full article